Yahoo
NasdaqCM - Nasdaq Real Time Price USD

Universe Pharmaceuticals INC (UPC)

4.5900 +0.0100 (+0.22%)
As of 10:38:05 AM EDT. Market Open.
Chart Range Bar
Loading chart for UPC
  • Previous Close 4.5800
  • Open 4.6094
  • Bid 3.3000 x 200
  • Ask 5.6400 x 200
  • Day's Range 4.2600 - 4.6200
  • 52 Week Range 2.0000 - 17.9600
  • Volume 5,705
  • Avg. Volume 2,083,742
  • Market Cap (intraday) 3.047M
  • Beta (5Y Monthly) 1.53
  • PE Ratio (TTM) --
  • EPS (TTM) -1.3800
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.

www.universe-pharmacy.com

216

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 9/1/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

UPC
20.47%
S&P 500 (^GSPC)
11.80%

1-Year Return

UPC
29.44%
S&P 500 (^GSPC)
18.47%

3-Year Return

UPC
99.48%
S&P 500 (^GSPC)
69.48%

5-Year Return

UPC
99.95%
S&P 500 (^GSPC)
69.17%

Statistics

View More

Valuation Measures

Annual
As of 8/27/2026
  • Market Cap

    3.37M

  • Enterprise Value

    -16.13M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.17

  • Price/Book (mrq)

    0.06

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -10.95%

  • Return on Assets (ttm)

    -1.72%

  • Return on Equity (ttm)

    -3.51%

  • Revenue (ttm)

    17.74M

  • Net Income Avi to Common (ttm)

    -1.94M

  • Diluted EPS (ttm)

    -1.3800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    29.05M

  • Total Debt/Equity (mrq)

    17.17%

  • Levered Free Cash Flow (ttm)

    -21.43M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

4.5900 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: